These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 15302797

  • 1. Plasma surfactant protein-B: a novel biomarker in chronic heart failure.
    De Pasquale CG, Arnolda LF, Doyle IR, Aylward PE, Chew DP, Bersten AD.
    Circulation; 2004 Aug 31; 110(9):1091-6. PubMed ID: 15302797
    [Abstract] [Full Text] [Related]

  • 2. Aminoterminal pro type B natriuretic peptide as a predictive and prognostic marker in patients with chronic heart failure.
    Rothenburger M, Wichter T, Schmid C, Stypmann J, Tjan TD, Berendes E, Etz C, Pioux A, Löher A, Wenzelburger F, Drees G, Hoffmeier A, Breithardt G, Scheld HH.
    J Heart Lung Transplant; 2004 Oct 31; 23(10):1189-97. PubMed ID: 15477114
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.
    Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M.
    Int J Cardiol; 2009 Jun 26; 135(2):165-74. PubMed ID: 18603317
    [Abstract] [Full Text] [Related]

  • 5. NT-proBNP in monitoring treatment of patients with congestive heart failure.
    Al-Meslmani BM, Fahoum SK, Shamia MG.
    Clin Lab; 2007 Jun 26; 53(1-2):35-9. PubMed ID: 17323823
    [Abstract] [Full Text] [Related]

  • 6. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S, Jankowska EA, Morgenthaler NG, Vassanelli C, Zanolla L, Rozentryt P, Filippatos GS, Doehner W, Koehler F, Papassotiriou J, Kremastinos DT, Banasiak W, Struck J, Ponikowski P, Bergmann A, Anker SD.
    J Am Coll Cardiol; 2007 Nov 13; 50(20):1973-80. PubMed ID: 17996563
    [Abstract] [Full Text] [Related]

  • 7. Plasma adiponectin, body mass index, and mortality in patients with chronic heart failure.
    Kistorp C, Faber J, Galatius S, Gustafsson F, Frystyk J, Flyvbjerg A, Hildebrandt P.
    Circulation; 2005 Sep 20; 112(12):1756-62. PubMed ID: 16157772
    [Abstract] [Full Text] [Related]

  • 8. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency.
    Toblli JE, Lombraña A, Duarte P, Di Gennaro F.
    J Am Coll Cardiol; 2007 Oct 23; 50(17):1657-65. PubMed ID: 17950147
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Usefulness of NT-ProBNP as a biomarker of clinical status in outpatients with chronic heart failure].
    Casado JM, Díaz A, Suárez C.
    Rev Esp Cardiol; 2008 Feb 23; 61(2):206-10. PubMed ID: 18364191
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Head-to-head comparison of BNP and IL-6 as markers of clinical and experimental heart failure: Superiority of BNP.
    Birner CM, Ulucan C, Fredersdorf S, Rihm M, Löwel H, Stritzke J, Schunkert H, Hengstenberg C, Holmer S, Riegger G, Luchner A.
    Cytokine; 2007 Nov 23; 40(2):89-97. PubMed ID: 17920926
    [Abstract] [Full Text] [Related]

  • 15. Correlation of B type natriuretic peptides with clinical and echocardiographic parameters in heterogeneous population of patients with symptoms suggestive of heart failure.
    Piechota WN, Piechota WT, Bejm J, Wierzbowski R, Michałkiewicz D.
    Adv Med Sci; 2006 Nov 23; 51():164-7. PubMed ID: 17357300
    [Abstract] [Full Text] [Related]

  • 16. N-terminal pro-brain natriuretic peptide, kidney disease and outcome in patients with chronic heart failure.
    Bruch C, Reinecke H, Stypmann J, Rothenburger M, Schmid C, Breithardt G, Wichter T, Gradaus R.
    J Heart Lung Transplant; 2006 Sep 23; 25(9):1135-41. PubMed ID: 16962477
    [Abstract] [Full Text] [Related]

  • 17. Utility of plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) to distinguish between congestive heart failure and non-cardiac causes of acute dyspnea in cats.
    Fox PR, Oyama MA, Reynolds C, Rush JE, DeFrancesco TC, Keene BW, Atkins CE, Macdonald KA, Schober KE, Bonagura JD, Stepien RL, Kellihan HB, Nguyenba TP, Lehmkuhl LB, Lefbom BK, Moise NS, Hogan DF.
    J Vet Cardiol; 2009 May 23; 11 Suppl 1():S51-61. PubMed ID: 19394287
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Levosimendan reduces plasma B-type natriuretic peptide and interleukin 6, and improves central hemodynamics in severe heart failure patients.
    Kyrzopoulos S, Adamopoulos S, Parissis JT, Rassias J, Kostakis G, Iliodromitis E, Degiannis D, Kremastinos DT.
    Int J Cardiol; 2005 Mar 30; 99(3):409-13. PubMed ID: 15771921
    [Abstract] [Full Text] [Related]

  • 20. Combined endurance/resistance training reduces NT-proBNP levels in patients with chronic heart failure.
    Conraads VM, Beckers P, Vaes J, Martin M, Van Hoof V, De Maeyer C, Possemiers N, Wuyts FL, Vrints CJ.
    Eur Heart J; 2004 Oct 30; 25(20):1797-805. PubMed ID: 15474694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.